|
1
|
Khan AJ, DiGiovanna MP, Ross DA, Sasaki
CT, Carter D, Son YH and Haffty BG: Adenoid cystic carcinoma: a
retrospective clinical review. Int J Cancer. 96:149–158. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chummun S, McLean NR, Kelly CG, Dawes PJ,
Meikle D, Fellows S and Soames JV: Adenoid cystic carcinoma of the
head and neck. Br J Plast Surg. 54:476–480. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wiseman SM, Popat SR, Rigual NR, Hicks WL
Jr, Orner JB, Wein RO, McGary CT and Loree TR: Adenoid cystic
carcinoma of the paranasal sinuses or nasal cavity: a 40-year
review of 35 cases. Ear Nose Throat J. 81:510–517. 2002.PubMed/NCBI
|
|
4
|
Hotte SJ, Winquist EW, Lamont E, MacKenzie
M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A and Siu LL: Imatinib
mesylate in patients with adenoid cystic carcinoma of the salivary
glands expressing c-kit: a Princess Margaret Hospital phase II
consortium study. J Clin Oncol. 23:585–590. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fordice J, Kershaw C, El-Naggar A and
Goepfert H: Adenoid cystic carcinoma of the head and neck:
predictors of morbidity and mortality. Arch Otolayrngol Head Neck
Surg. 125:149–152. 1999. View Article : Google Scholar
|
|
6
|
Batsakis JG: Nerves and neurotropic
carcinomas. Ann Otol Rhinol Laryngol. 94:426–427. 1985.PubMed/NCBI
|
|
7
|
Hassan MO and Maksem J: The prostatic
perineural space and its relation to tumor spread: an
ultrastructural study. Am J Surg Pathol. 4:143–148. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rodin AE, Larson DL and Roberts DK: Nature
of the perineural space invaded by prostatic carcinoma. Cancer.
20:1772–1779. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ozaki H, Hiraoka T, Mizumoto R, Matsuno S,
Matsumoto Y, Nakayama T, Tsunoda T, Suzuki T, Monden M, Saitoh Y,
Yamauchi H and Ogata Y: The prognostic significance of lymph node
metastasis and intrapancreatic perineural invasion in pancreatic
cancer after curative resection. Surg Today. 29:16–22. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Law WL and Chu KW: Anterior resection for
rectal cancer with mesorectal excision: a prospective evaluation of
622 patients. Ann Surg. 240:260–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beard CJ, Chen MH, Cote K, Loffredo M,
Renshaw AA, Hurwitz M and D’Amico AV: Perineural invasion is
associated with increased relapse after external beam radiotherapy
for men with low-risk prostate cancer and may be a marker for
occult, high-grade cancer. Int J Radiat Oncol Biol Phys. 58:19–24.
2004. View Article : Google Scholar
|
|
12
|
Su CH, Tsay SH, Wu CC, Shyr YM, King KL,
Lee CH, Lui WY, Liu TJ and P’eng FK: Factors influencing
postoperative morbidity, mortality, and survival after resection
for hilar cholangiocarcinoma. Ann Surg. 223:384–394. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duraker N, Sişman S and Can G: The
significance of perineural invasion as a prognostic factor in
patients with gastric carcinoma. Surg Today. 33:95–100. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Savagner P: Leaving the neighborhood:
molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jechlinger M, Grunert S, Tamir IH, Janda
E, Lüdemann S, Waerner T, Seither P, Weith A, Beug H and Kraut N:
Expression profiling of epithelial plasticity in tumor progression.
Oncogene. 22:7155–7169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi Y and Massagué J: Mechanisms of TGF-β
signaling from cell membrane to the nucleus. Cell. 113:685–700.
2003. View Article : Google Scholar
|
|
18
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: new insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hennessy BT, Gonzalez-Angulo AM,
Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J,
Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M,
Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J,
Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM and
Mills GB: Characterization of a naturally occurring breast cancer
subset enriched in epithelial-to-mesenchymal transition and stem
cell characteristics. Cancer Res. 69:4116–4124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tarin D, Thompson EW and Newgreen DF: The
fallacy of epithelial mesenchymal transition in neoplasia. Cancer
Res. 65:5996–6001. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klymkowsky MW and Savagner P:
Epithelial-mesenchymal transition: a cancer researcher’s conceptual
friend and foe. Am J Pathol. 174:1588–1593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Greenblatt MS, Bennett WP, Hollstein M and
Harris CC: Mutations in the p53 tumor suppressor gene: clues to
cancer etiology and molecular pathogenesis. Cancer Res.
54:4855–4878. 1994.PubMed/NCBI
|
|
23
|
Brosh R and Rotter V: When mutants gain
new powers: news from the mutant p53 field. Nat Rev Cancer.
9:701–713. 2009.PubMed/NCBI
|
|
24
|
Chen W, Zhang HL, Shao XJ, Jiang YG, Zhao
XG, Gao X, Li JH, Liu BL and Sun MY: Gene expression profile of
salivary adenoid cystic carcinoma associated with perinerual
invasion. Tohoku J Exp Med. 212:319–334. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang CJ, Chao CH, Xia W, Yang JY, Xiong
Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH and Hung MC: p53
regulates epithelial-mesenchymal transition and stem cell
properties through modulating miRNAs. Nat Cell Biol. 13:317–323.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tuschl T: Expanding small RNA
interference. Nat Biotechnol. 20:446–448. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dong L, Ge XY, Wang YX, Yang LQ, Li SL, Yu
GY, Gao Y and Fu J: Transforming growth factor-β and
epithelial-mesenchymal transition are associated with pulmonary
metastasis in adenoid cystic carcinoma. Oral Oncol. 49:1051–1058.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zou W, Yang H, Hou X, Zhang W, Chen B and
Xin X: Inhibition of CD147 gene expression via RNA interference
reduces tumor cell invasion, tumorigenicity and increase
chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett.
248:211–218. 2007. View Article : Google Scholar
|
|
29
|
Chen W, Zhang HL, Jiang YG, Li JH, Liu BL
and Sun MY: Inhibition of CD146 gene expression via RNA
interference reduces in vitro perineural invasion on ACC-M cells. J
Oral Pathol Med. 38:198–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang L, Sun M, Jiang Y, Yang L, Lei D, Lu
C, Zhao Y, Zhang P, Yang Y and Li J: Nerve growth factor and
tyrosine kinase A in human salivary adenoid cystic carcinoma:
expression patterns and effects on in vitro invasive behavior. J
Oral Maxillofac Surg. 64:636–641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giono LE and Manfredi JJ: The p53 tumor
suppressor participates in multiple cell cycle checkpoints. J Cell
Physiol. 209:13–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen L, Park SM, Tumanov AV, Hau A, Sawada
K, Feig C, Turner JR, Fu YX, Romero IL, Lengyel E and Peter ME:
CD95 promotes tumour growth. Nature. 465:492–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eliyahu D, Michalovitz D, Eliyahu S,
Pinhasi-Kimhi O and Oren M: Wild-type p53 can inhibit
oncogene-mediated focus formation. Proc Natl Acad Sci USA.
86:8763–8767. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baker SJ, Markowitz S, Fearon ER, Willson
JK and Vogelstein B: Suppression of human colorectal carcinoma cell
growth by wild-type p53. Science. 249:912–915. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Diller L, Kassel J, Nelson CE, Gryka MA,
Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B,
et al: p53 functions as a cell cycle control protein in
osteosarcomas. Mol Cell Biol. 10:5772–5781. 1990.PubMed/NCBI
|
|
36
|
Michalovitz D, Halevy O and Oren M:
Conditional inhibition of transformation and of cell proliferation
by a temperature-sensitive mutant of p53. Cell. 62:671–680. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martinez J, Georgoff I, Martinez J and
Levine AJ: Cellular localization and cell cycle regulation by a
temperature-sensitive p53 protein. Genes Dev. 5:151–159. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang WW, Fang X, Mazur W, French BA,
Georges RN and Roth JA: High-efficiency gene transfer and
high-level expression of wild-type p53 in human lung cancer cells
mediated by recombinant adenovirus. Cancer Gene Ther. 1:5–13.
1994.PubMed/NCBI
|
|
39
|
Roth JA, Nguyen D, Lawrence DD, Kemp BL,
Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC,
Pisters KM, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM,
Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ,
Mukhopadhyay T and Cai D: Retrovirus-mediated wild-type p53 gene
transfer to tumors of patients with lung cancer. Nat Med.
2:985–991. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shimada H, Matsubara H, Shiratori T,
Shimizu T, Miyazaki S, Okazumi S, Nabeya Y, Shuto K, Hayashi H,
Tanizawa T, Nakatani Y, Nakasa H, Kitada M and Ochiai T: Phase I/II
adenoviral p53 gene therapy for chemoradiation resistant advanced
esophageal squamous cell carcinoma. Cancer Sci. 97:554–561. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brown CJ, Lain S, Verma CS, Fersht AR and
Lane DP: Awakening guardian angels: drugging the P53 pathway. Nat
Rev Cancer. 9:862–873. 2009. View Article : Google Scholar : PubMed/NCBI
|
